Shares of CRH Medical Corp (NYSEARCA:CRHM) have been assigned an average rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $7.50.

Several analysts recently issued reports on CRHM shares. Zacks Investment Research cut shares of CRH Medical Corp from a “hold” rating to a “sell” rating in a research note on Tuesday, April 11th. Scotiabank cut shares of CRH Medical Corp from an “outperform” rating to a “sector perform” rating in a research note on Friday, July 14th. CIBC cut shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a research note on Monday, July 17th. Canaccord Genuity reissued a “buy” rating and issued a $8.00 price target on shares of CRH Medical Corp in a research note on Monday, July 17th. Finally, TD Securities cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Tuesday, July 18th.

COPYRIGHT VIOLATION NOTICE: “CRH Medical Corp (NYSEARCA:CRHM) Given Consensus Recommendation of “Buy” by Brokerages” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/08/crh-medical-corp-nysearcacrhm-given-consensus-recommendation-of-buy-by-brokerages.html.

CRH Medical Corp (NYSEARCA CRHM) opened at 2.60 on Tuesday. The company has a 50 day moving average of $4.77 and a 200-day moving average of $6.37. CRH Medical Corp has a one year low of $2.50 and a one year high of $9.25.

Several institutional investors have recently modified their holdings of the company. ARP Americas LLC raised its position in shares of CRH Medical Corp by 7.4% in the first quarter. ARP Americas LLC now owns 13,042 shares of the company’s stock valued at $107,000 after buying an additional 900 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in CRH Medical Corp by 15,344.4% in the first quarter. Tower Research Capital LLC TRC now owns 13,900 shares of the company’s stock worth $114,000 after buying an additional 13,810 shares during the period. Acadian Asset Management LLC acquired a new stake in CRH Medical Corp during the first quarter worth about $150,000. KCG Holdings Inc. raised its stake in CRH Medical Corp by 40.1% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company’s stock worth $160,000 after buying an additional 5,579 shares during the period. Finally, Bank of Montreal Can raised its stake in CRH Medical Corp by 128.4% in the second quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock worth $164,000 after buying an additional 16,135 shares during the period.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.